Aventis Pharma Limited

In May 1956, Aventis Pharma Limited was established as Hoechst Fedco Pharma Private Ltd. With 50.1% holding of paid-up share capital, Sanofi-aventis is the major shareholder of Aventis Pharma Ltd.

Aventis is currently present in over 100 countries with its global headquarters in Paris, France. The total employee strength worldwide is about 100,000, including 11000 scientists. Product portfolio of Aventis includes medicines in the area of cardiovascular disease, thrombosis, diabetes, bone disease, epilepsy and cancer. It has 20 research centers in three continents, with R&D budget of about 4 billion euros.
Aventis Pharma Ltd. India has 2 state-of-art manufacturing facilities at Ankleshwar (Gujarat) and at Verna (Goa). These sites have been identified as the global sourcing units.

The company is working to bring innovative products so as to make the necessary treatments more widely available. In India it has employee strength of about 1840.

Corporate Address
Aventis House

54/A, Sir Mathuradas Vasanji Road,
Andheri (E),
Mumbai – 400 093
India.
Ph: 91-22-28278000
Fax: 91-22-28370939

Quarterly Results of Aventis

Quarterly Results (Rs.in Millions)
Dec 2006(3 rd quarter) Sept 2006(2nd quarter) Dec 2005(3 rd quarter)
Sales Turnover 2572 2364 2375
Other Income 156 90 78
Total Income 2728 2454 2453
Total Expenditure 1885 1745 1656
Operating Profit 843 709 797
Interest 0 1 0
Gross Profit 843 708 797
Depreciation 43 42 43
Tax 262 227 257

*Source: economictimes.indiatimes.com

Quarterly Results (in %)
% Change (Over Sep 2006) % Change (Over Dec 2005)
Sales Turnover 8.8 8.29
Other Income 73.33 100
Total Income 11.17 11.21
Total Expenditure 8.02 13.83
Operating Profit 18.9 5.77
Interest -100 0
Gross Profit 19.07 5.77
Depreciation 2.38 0
Tax
Reported PAT 22.55 8.25

*Source: economictimes.indiatimes.com

Annual Results of Aventis

Annual Unaudited Results (Rs. in Millions)
(12 Months) (12 Months) % Changes
Sales Turnover 8581.00 7864.00 9.12
Other Income 295 218 35.32
Total Income 8876.00 8082.00 9.82
Total Expenditure 6340.00 5719.00 10.86
Operating Profit 2536.00 2363.00 7.32
Interest 0 1 -100
Gross Profit 2536.00 2362.00 7.37
Depreciation 172 168 2.38
Tax 913 777 17.5
Reported PAT 1451.00 1485.00 -2.29

Leave a Reply

Your email address will not be published. Required fields are marked *